Edesa Biotech CEO acquires 27,602 shares in grant
The annual base salary increase to $657,423 was retroactive for July 1 through October 10, 2026, with 90% of monthly base salary otherwise payable in cash awarded as RSUs.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Edesa Biotech, Inc. (EDSA) Chief Executive Officer Pardeep Nijhawan acquired 27,602 shares through restricted share units on October 28, 2026; the units vested in full upon grant under the 2019 Equity Incentive Compensation Plan. The award was received in lieu of 90% of monthly base salary otherwise payable in cash, following an annual base salary increase from $357,696 to $657,423, retroactive from July 1 through October 10, 2026. Nijhawan’s direct holdings after the grant were 933,595 shares.
Insider Trade Summary
Grant/Award: 27,602 shares
Grant/Award
1 txn
Insider
Nijhawan Pardeep
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares F1 | 27,602 | $0.00 | $0.00 |
| Holding | Common Shares F2 | -- | -- | -- |
| Holding | Common Shares F3 | -- | -- | -- |
| Holding | Common Shares F2 | -- | -- | -- |
| Holding | Common Shares F2 | -- | -- | -- |
Holdings After Transaction:
Common Shares — 933,595 shares (Direct);
Common Shares — 402,702 shares (Indirect, Held by Pardeep Nijhawan Medicine Professional Corporation);
Common Shares — 32,609 shares (Indirect, Held by The New Nijhawan Family Trust 2015);
Common Shares — 32,013 shares (Indirect, Held by The Digestive Health Clinic Inc.);
Common Shares — 53,104 shares (Indirect, Held by 1968160Ontario Inc.)
Footnotes (3)
- F1. Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These restricted stock awards ("RSUs") represent awards received in lieu of 90% of Reporting Person's monthly base salary otherwise payable in cash, reflecting the increase in Reporting Person's annual base salary from $357,696 to $657,423, retroactive for the period from July 1, 2026 through October 10, 2026. The number of RSUs was determined by dividing such portion of the base salary by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through October 27, 2026.
- F2. Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F3. Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Shares acquired through restricted share units: 27,602 shares
Direct shares following transaction: 933,595 shares
Shares held by Pardeep Medicine Professional Corporation: 402,702 shares
+5 more
8 metrics
Shares acquired through restricted share units
27,602 shares
Vested in full upon grant on October 28, 2026.
Direct shares following transaction
933,595 shares
Reported after the October 28, 2026 grant.
Shares held by Pardeep Medicine Professional Corporation
402,702 shares
Pardeep Nijhawan is reported to wholly own the corporation and disclaims beneficial ownership except to the extent of his pecuniary interest.
Shares held by The New Nijhawan Family Trust 2015
32,609 shares
Pardeep Nijhawan is a co-trustee and disclaims beneficial ownership except to the extent of his pecuniary interest.
Shares held by The Digestive Health Clinic Inc.
32,013 shares
The corporation is reported as wholly owned by Pardeep Nijhawan.
Shares held by 1968160 Ontario Inc.
53,104 shares
The corporation is reported as wholly owned by Pardeep Nijhawan.
Annual base salary before increase
$357,696 per year
Amount before the stated increase.
Annual base salary after increase
$657,423 per year
Increase was retroactive from July 1, 2026 through October 10, 2026.
Key Terms
restricted share units, 2019 Equity Incentive Compensation Plan, volume weighted average price (VWAP), pecuniary interest
4 terms
2019 Equity Incentive Compensation Plan technical
"pursuant to the Issuer's 2019 Equity Incentive Compensation Plan"
volume weighted average price (VWAP) financial
"5-day volume weighted average price (VWAP) of the Issuer's common shares"
Volume weighted average price (VWAP) is the average price a security traded at over a specific period, where each trade is weighted by the number of shares traded so larger trades count more. Think of it like an average price at a market where bulk purchases move the average more than small ones. Investors use VWAP as a performance benchmark and a reference point to judge whether a buy or sell happened at a good price and to guide trading decisions.
pecuniary interest regulatory
"except to the extent of his pecuniary interest therein"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did EDSA grant RSUs to Pardeep Nijhawan?
The RSUs were received in lieu of 90% of his monthly base salary otherwise payable in cash. His annual base salary increased from $357,696 to $657,423, retroactive from July 1, 2026 through October 10, 2026. The RSU count was calculated using the 5-day volume weighted average price through October 27, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
